UNSPSC 51343004: Stavudine or stavidine

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BO9LE4QFZF. European Medicines Agency schedules Stavudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10642MIG. Stavudine generally arises in the molecular formula C10H12N2O4. The term STAVUDINE is an International Non-Proprietary Name or INN. STAVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Stavudine or stavidine bears US NLM identifiers UMLS ID C0164662 and NCI Concept Code C1428. SMILES: CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO.

UNSPSC 51343004 Stavudine or stavidine is a Commodity code that, based on recent state and local activity, shows minimal relevant procurement. The recent opportunities tagged under this code involve naloxone (an opioid antagonist) and antibiotic pharmaceuticals (doxycycline and ciprofloxacin), neither of which aligns with stavudine — an antiretroviral medication used in HIV treatment. State and local governments do procure pharmaceuticals through cooperative purchasing vehicles and piggyback agreements, typically via state health departments and county community health systems, but the specific products being solicited under this code do not match its nominal scope of stavudine procurement.

The Illinois Department of Public Health awarded a pharmaceutical piggyback contract to Chartwell Rx LLC on August 28, 2026 for doxycycline and ciprofloxacin through the MMCAP Infuse consortium, totaling $2,999,999.11 over 12 months plus two renewal years; Seminole County, Florida posted an IFB on June 30, 2026 for naloxone and drug deactivation systems with a response deadline of July 26, 2023. The code shows no recent activity directly tied to stavudine procurement, indicating either low state and local demand for this specific antiretroviral or a categorization mismatch in the opportunities database. Firms tracking this code for business development purposes should verify whether state and local health agencies are actively procuring stavudine through other UNSPSC codes or cooperative vehicles before allocating pursuit resources.